Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2010 Feb 1.

Published in final edited form as: Med Care. 2009 Feb;47(2):199–207. doi: 10.1097/MLR.0b013e31818475b7

Table 5.

Adjusted Predicted Probabilities of Meeting Medication and Visit Treatment Quality Standards

Characteristic	Acute Phase				Maintenance Phase
Characteristic	Medication Quality^*		Visit Continuity		Medication Quality^*		Visit Continuity
	Mean Probability	s.d.	Mean Probability	s.d.	Mean Probability	s.d.	Mean Probability	s.d.
Substance Use Disorder	.41	.046	.33	.068	.32	.037	.20	.075
No Substance Use Disorder	.49	.048	.41	.074	.43	.042	.19	.071
Male	.43	.063	.34	.078	.39	.061	.18	.070
Female	.45	.064	.36	.081	.40	.062	.19	.072
White	.45	.065	.36	.076	.42	.055	.20	.074
Black	.42	.059	.33	.080	.35	.053	.17	.063
Hispanic	.50	.049	.39	.087	.45	.049	.13	.053
Age 20-39	.47	.048	.43	.075	.41	.041	.20	.074
Age 40-64	.49	.048	.41	.073	.42	.041	.19	.071

^*

Patients receiving decanoate not included in analysis